Steven P. Coen
CIK 1977441 · View on SEC EDGAR ↗
First SEC filing: March 10, 2025 · Latest: March 10, 2025
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 17, 2026 | DNA | S | 752 | $7.90 | $5,941 | 51,438 Direct | -1.44% | Disposed | -4.0% (price as of 2026-08-20) |
| May 21, 2025 | DNA | S | 346 | $7.58 | $2,623 | 9,216 Direct | -3.62% | Disposed | 0.1% (price as of 2026-08-20) |
| April 21, 2025 | DNA | S | 997 | $7.28 | $7,258 | 8,819 Direct | -10.16% | Disposed | 4.2% (price as of 2026-08-20) |
| March 4, 2025 | DNA | S | 395 | $7.72 | $3,049 | 8,012 Direct | -4.70% | Disposed | -1.7% (price as of 2026-08-20) |
| Feb. 4, 2025 | DNA | S | 367 | $13.44 | $4,932 | 7,664 Direct | -4.57% | Disposed | -43.6% (price as of 2026-08-20) |
| Jan. 6, 2025 | DNA | S | 324 | $11.72 | $3,797 | 7,288 Direct | -4.26% | Disposed | -35.3% (price as of 2026-08-20) |
| Dec. 4, 2024 | DNA | S | 330 | $9.64 | $3,181 | 6,869 Direct | -4.58% | Disposed | -21.3% (price as of 2026-08-20) |
| Nov. 4, 2024 | DNA | S | 333 | $7.58 | $2,524 | 6,456 Direct | -4.90% | Disposed | 0.1% (price as of 2026-08-20) |
| Oct. 4, 2024 | DNA | S | 306 | $8.35 | $2,555 | 6,046 Direct | -4.82% | Disposed | -9.2% (price as of 2026-08-20) |
| Sept. 12, 2024 | DNA | S | 316 | $6.17 | $1,950 | 5,609 Direct | -5.33% | Disposed | 22.9% (price as of 2026-08-20) |
| Aug. 2, 2024 | DNA | S | 17,486 | $0.29 | $5,071 | 207,318 Direct | -7.78% | Disposed | -34.6% (price as of 2026-08-20) |
| July 2, 2024 | DNA | S | 13,520 | $0.33 | $4,462 | 195,058 Direct | -6.48% | Disposed | -42.5% (price as of 2026-08-20) |
| June 3, 2024 | DNA | S | 13,440 | $0.55 | $7,392 | 178,832 Direct | -6.99% | Disposed | -65.5% (price as of 2026-08-20) |
| May 2, 2024 | DNA | S | 131,928 | $0.84 | $110,820 | 162,527 Direct | -44.80% | Disposed | -77.4% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 16, 2026 | DNA | Restricted Stock Units | Class A Common Stock (312) | — | — | 312 | Disposed |
| July 16, 2026 | DNA | Restricted Stock Units | Class A Common Stock (1,174) | — | — | 1,174 | Disposed |
| May 20, 2025 | DNA | Restricted Stock Units | Class A Common Stock (587) | — | — | 587 | Disposed |
| May 20, 2025 | DNA | Restricted Stock Units | Class A Common Stock (156) | — | — | 156 | Disposed |
| April 17, 2025 | DNA | Restricted Stock Units | Class A Common Stock (1,061) | — | — | 1,061 | Disposed |
| April 17, 2025 | DNA | Restricted Stock Units | Class A Common Stock (156) | — | — | 156 | Disposed |
| April 17, 2025 | DNA | Restricted Stock Units | Class A Common Stock (587) | — | — | 587 | Disposed |
| March 6, 2025 | DNA | Restricted Stock Units | Class A Common Stock (4,245) | — | — | 4,245 | Acquired |
| March 3, 2025 | DNA | Restricted Stock Units | Class A Common Stock (156) | — | — | 156 | Disposed |
| March 3, 2025 | DNA | Restricted Stock Units | Class A Common Stock (587) | — | — | 587 | Disposed |
| Feb. 3, 2025 | DNA | Restricted Stock Units | Class A Common Stock (156) | — | — | 156 | Disposed |
| Feb. 3, 2025 | DNA | Restricted Stock Units | Class A Common Stock (587) | — | — | 587 | Disposed |
| Jan. 3, 2025 | DNA | Restricted Stock Units | Class A Common Stock (156) | — | — | 156 | Disposed |
| Jan. 3, 2025 | DNA | Restricted Stock Units | Class A Common Stock (587) | — | — | 587 | Disposed |
| Dec. 3, 2024 | DNA | Restricted Stock Units | Class A Common Stock (156) | — | — | 156 | Disposed |
| Dec. 3, 2024 | DNA | Restricted Stock Units | Class A Common Stock (587) | — | — | 587 | Disposed |
| Nov. 1, 2024 | DNA | Restricted Stock Units | Class A Common Stock (156) | — | — | 156 | Disposed |
| Nov. 1, 2024 | DNA | Restricted Stock Units | Class A Common Stock (587) | — | — | 587 | Disposed |
| Oct. 3, 2024 | DNA | Restricted Stock Units | Class A Common Stock (156) | — | — | 156 | Disposed |
| Oct. 3, 2024 | DNA | Restricted Stock Units | Class A Common Stock (587) | — | — | 587 | Disposed |
| Sept. 11, 2024 | DNA | Restricted Stock Units | Class A Common Stock (156) | — | — | 156 | Disposed |
| Sept. 11, 2024 | DNA | Restricted Stock Units | Class A Common Stock (587) | — | — | 587 | Disposed |
| Aug. 1, 2024 | DNA | Restricted Stock Units | Class A Common Stock (6,250) | — | — | 6,250 | Disposed |
| Aug. 1, 2024 | DNA | Restricted Stock Units | Class A Common Stock (23,496) | — | — | 23,496 | Disposed |
| July 1, 2024 | DNA | Restricted Stock Units | Class A Common Stock (6,250) | — | — | 6,250 | Disposed |
| July 1, 2024 | DNA | Restricted Stock Units | Class A Common Stock (23,496) | — | — | 23,496 | Disposed |
| May 31, 2024 | DNA | Restricted Stock Units | Class A Common Stock (6,249) | — | — | 6,249 | Disposed |
| May 31, 2024 | DNA | Restricted Stock Units | Class A Common Stock (23,496) | — | — | 23,496 | Disposed |
| May 1, 2024 | DNA | Restricted Stock Units | Class A Common Stock (12,500) | — | — | 12,500 | Disposed |
| May 1, 2024 | DNA | Restricted Stock Units | Class A Common Stock (281,955) | — | — | 281,955 | Disposed |
| March 7, 2024 | DNA | Restricted Stock Units | Class A Common Stock (300,000) | — | — | 300,000 | Acquired |
| July 28, 2023 | DNA | Restricted Stock Units | Class A Common Stock (1,127,820) | — | — | 1,127,820 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $433,692 | — | — | — | — | — | $5,000 | $1,332,326 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.